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Osteoporosis is a global epidemic, characterised by low bone
mass and altered micro-architecture of the bone.1 The popula-
tion at risk of fractures due to fragile bones is expected to
increase by over two-folds by the year 2040; and the burden
rises with ageing populations.2  The situation is,  especially,
alarming in the Asia-Pacific region, where the population over
65 years is expected to quadruple by 2050, with over half of
the  hip fractures in the world predicted to occur in the Asia-Pa-
cific by that year.3
The  Asia-Pacific  Consortium  on  Osteoporosis  (APCO)  was
launched in May 2019. Its vision is to reduce the burden of
osteoporosis and its associated complication of fractures in
the Asia- Pacific. APCO is comprised of 39 experts in osteo-
porosis from 19 countries and regions.4 APCO determined that
the existing clinical guidelines for osteoporosis in countries in
the Asia- Pacific were too varied in scope and recommenda-
tions, through a comprehensive and comparative review. In
addition, there are many low- and middle-income countries
(LMICs) where no guidelines exist.
The  first  APCO’s  project  was,  therefore,  to  formulate
harmonised pan Asia-Pacific clinical practice standards (The
Framework) for the screening, diagnosis, and management of
osteoporosis. A ‘5IQ’ approach identification, investigation,
information,  intervention,  integration  and  quality,  was
employed to identify key elements in the various national and
regional guidelines for consideration to be included as stan-
dards of care. APCO members then shaped The Framework by
reaching  a  consensus  using  the  Delphi  technique  through
multiple rounds of structured questionnaires.5
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The Framework is a guidance document, proposing minimum
practice standards for osteoporosis management, focusing on
a  broad  range  of  high-risk  groups,  including  patients  who
already have had a fragility fracture, patients who are at a
higher risk according to country-specific fracture intervention
threshold and other high-risk groups, such as patients living
with conditions/or are on medications that predispose to bone
loss. An aspirational and readily measurable guidance, it is
hoped  that  the  clinical  guidelines  on  osteoporosis  in  the
various  countries  of  the  Asia-Pacific  will  be  benchmarked
against the scope and standards of care proposed in the frame-
work.
In Pakistan, accurate data on osteoporosis is absent due to
limited number of epidemiological studies. Available studies
report lack of DEXA machines availability with a high burden of
osteoporosis on heel ultrasound scanning. Clinical guidelines
are  non-existent;  and  there  is  no  available  report  of
compliance to any action plan in clinical practice throughout
Pakistan.6
However, prevalence and associated complications of osteo-
porosis  are expected to rise due to an aging population,  a
sedentary lifestyle and urbanisation. The International Osteo-
porosis Foundation (IOF) reports that as of 2012, 9.91 million
people in Pakistan have osteoporosis, and this is estimated to
increase to 11.3 million in 2020 and to 12.91 million by 2050.7
Despite its common occurrence and availability of advanced
diagnostic and treatment modalities, there is lack of optimum
utilisation of resources, investigation and treatment. Definite
epidemiological data in the country is lacking and risk factors
such as multi-parity, longer life span after menopause, low
dietary calcium intake, vitamin D deficiency, and physical inac-
tivity  are  on  a  perpetual  rise.  Different  local  studies  have
reported the frequency of osteoporosis from 5.6 to 17.8% in
pre-menopausal and 20-49.3% in postmenopausal women.6  
Since the diagnosis and treatment of osteoporosis lies at an
intersection of multiple clinical specialties (endocrinology, rheu-
matology,  orthopedic  surgery,  pathology,  family  medicine,
etc.), the management is not methodical, and the disease often
gets overlooked or mismanaged owing to a lack of responsibility
assertion by any medical specialty. There is an acute need to
take steps to develop guidelines for diagnosis, treatment and
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prevention of osteoporosis, dissemination of the resulting guide-
lines to the physicians across the country, and for inclusion of
osteoporosis as a priority in the National Action Plan by the
Government of Pakistan.
The  way  forward  for  Pakistan  is  to  develop  country-specific
national  guidelines using the clinical  standards in the APCO
Framework as a benchmark. Implementation of the clinical prac-
tice guidelines, thus developed, is expected to enable imple-
mentation  of  programmes  for  prevention  and  treatment  of
osteoporotic fractures, fracture liaison services (FLS) for preven-
tion of secondary fracture prevention (SFP) and provincial and
national fragility fracture networks. Real epidemiological data,
produced through registries, will enable identification of  knowl-
edge gaps, and drive multi-sector action focusing on the preven-
tive  and  management  aspects  of  osteoporosis  throughout
Pakistan.
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